Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
about
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
description
clinical trial
@en
klinisch onderzoek
@nl
name
Immunogenicity & Safety Study ...... bella-varicella Vaccine 208136
@en
type
label
Immunogenicity & Safety Study ...... bella-varicella Vaccine 208136
@en
prefLabel
Immunogenicity & Safety Study ...... bella-varicella Vaccine 208136
@en
P1050
P1476
Immunogenicity & Safety Study ...... bella-varicella Vaccine 208136
@en
P3098
NCT00751348
P580
2008-10-01T00:00:00Z
P582
2010-05-27T00:00:00Z